november AG

euro adhoc: november AG
Restructuring & Recapitalisations
BAFin relieves BIOMED Beteiligungsgesellschaft and Dr. Claus Müller from submitting a mandatory offer

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

16.11.2007

Erlangen, 16. November 2007. November AG has been notified that BAFIN relieves BIOMED and Dr. Claus Müller from submitting a mandatory offer under section 37 of the german securities acquisitions and takeover act (wpüg) in conjunction with section 9 of the Offer regulations in case they gain control of the company. Submitting such an offer would have been mandatory if a shareholder holds at least 30% of a company's voting shares.

The decision made by bafin also makes it possible to implement the decisions made on 22th may 2007 at the annual general meeting (AGM)of the company.

@@start.t2@@end of announcement                                                 euro adhoc 16.11.2007 14:24:07
--------------------------------------------------------------------------------@@end@@

ots Originaltext: november AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN:      DE0006762909
WKN:        676290
Index:    CDAX, Technologie All Share, Prime All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade



Weitere Meldungen: november AG

Das könnte Sie auch interessieren: